Renewal of govt’s APPL deals to steer Duopharma

Share this page

Duopharma Biotech Bhd’s dominant market position in the local generic drug manufacturing means it is well placed to capitalise on any rise in out-of-pocket health expenditure at the pharmacies. Read full story

Date: April 10, 2025 6:00 am
Source: thestar.com.my


💡 Want your business featured here?
Click here to advertise with us →
Scroll to Top